The t(X;l)(p11.2;q21.2) translocation in papillary renal cell carcinoma fuses a novel gene PRCC to the TFE3 transcription factor gene

被引:219
作者
Sidhar, SK
Clark, J
Gill, S
Hamoudi, R
Crew, AJ
Gwilliam, R
Ross, M
Linehan, WM
Birdsall, S
Shipley, J
Cooper, CS
机构
[1] INST CANC RES, HADDOW LABS, MOL CARCINOGENESIS SECT, SUTTON SM2 5NG, SURREY, ENGLAND
[2] INST CANC RES, HADDOW LABS, CELL BIOL & EXPT PATHOL SECT, SUTTON SM2 5NG, SURREY, ENGLAND
[3] INST CANC RES, HADDOW LABS, CANC GENE CLONING LAB, SUTTON SM2 5NG, SURREY, ENGLAND
[4] SANGER CTR, CAMBRIDGE CB10 1RQ, ENGLAND
[5] NCI, UROL ONCOL SECT, BETHESDA, MD 20892 USA
[6] ST VINCENT HOSP, GARVAN INST, SYDNEY, NSW, AUSTRALIA
基金
英国惠康基金;
关键词
D O I
10.1093/hmg/5.9.1333
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The specific chromosomal translocation t(X;1)(p11,2;q21,2) has been observed in human papillary renal cell carcinomas, In this study we demonstrated that this translocation results in the fusion of a novel gene designated PRCC at 1q21,2 to the TFE3 gene at Xp11,2, TFE3 encodes a member of the basic helix-loop-helix (bHLH) family of transcription factors originally identified by its ability to bind to mu E3 elements in the immunoglobin heavy chain intronic enhancer, The translocation is predicted to result in the fusion of the N-terminal region of the PROC protein, which includes a proline-rich domain, to the entire TFE3 protein, Notably the generation of the chimaeric PRCC-TFE3 gene appears to be accompanied by complete loss of normal TFE3 transcripts, This work establishes that the disruption of transcriptional control by chromosomal translocation is important in the development of kidney carcinoma in addition to its previously established role in the aetiology of sarcomas and leukaemias.
引用
收藏
页码:1333 / 1338
页数:6
相关论文
共 37 条
[1]  
ANGLARD P, 1992, CANCER RES, V52, P348
[2]   TFE3 CONTAINS 2 ACTIVATION DOMAINS, ONE ACIDIC AND THE OTHER PROLINE-RICH, THAT SYNERGISTICALLY ACTIVATE TRANSCRIPTION [J].
ARTANDI, SE ;
MERRELL, K ;
AVITAHL, N ;
WONG, KK ;
CALAME, K .
NUCLEIC ACIDS RESEARCH, 1995, 23 (19) :3865-3871
[3]   THE BASIC HELIX-LOOP-HELIX-ZIPPER DOMAIN OF TFE3 MEDIATES ENHANCER-PROMOTER INTERACTION [J].
ARTANDI, SE ;
COOPER, C ;
SHRIVASTAVA, A ;
CALAME, K .
MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (12) :7704-7716
[4]   TFE3 - A HELIX LOOP HELIX PROTEIN THAT ACTIVATES TRANSCRIPTION THROUGH THE IMMUNOGLOBULIN ENHANCER MU-E3 MOTIF [J].
BECKMANN, H ;
SU, LK ;
KADESCH, T .
GENES & DEVELOPMENT, 1990, 4 (02) :167-179
[5]  
BONGARZONE I, 1989, ONCOGENE, V4, P1457
[6]  
Byrne PC, 1996, HUM GENET, V97, P340
[7]   IDENTIFICATION OF NOVEL GENES, SYT AND SSX, INVOLVED IN THE T(X18)(P11.2Q11.2) TRANSLOCATION FOUND IN HUMAN SYNOVIAL SARCOMA [J].
CLARK, J ;
ROCQUES, PJ ;
CREW, AJ ;
GILL, S ;
SHIPLEY, J ;
CHAN, AML ;
GUSTERSON, BA ;
COOPER, CS .
NATURE GENETICS, 1994, 7 (04) :502-508
[8]  
Clark J, 1996, ONCOGENE, V12, P229
[9]   ONCOGENIC CONVERSION OF TRANSCRIPTION FACTORS BY CHROMOSOMAL TRANSLOCATIONS [J].
CLEARY, ML .
CELL, 1991, 66 (04) :619-622
[10]   CYTOGENETICS OF A RENAL ADENOCARCINOMA IN A 2-YEAR-OLD CHILD [J].
DEJONG, B ;
MOLENAAR, IM ;
LEEUW, JA ;
IDENBERG, VJS ;
OOSTERHUIS, JW .
CANCER GENETICS AND CYTOGENETICS, 1986, 21 (02) :165-169